Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2010 / Cilt: 20 - Sayı: 3

Endometriyal kanserlerde “vanishing cancer phenomenon”: üç klinik vaka ve Literatür değerlendirmesi

‘’Vanishing cancer phenomenon’’ in endometrial cancers: a report of three cases and review of the literature

Pages
175–181
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, recognition of the concept, the vanishing endometrial carcinoma, might be a useful for gyneco logic pathologist and gynecologic oncologist in order to prevent mismanagement and medico-legal ligitation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:“Vanishing carcinoma” phenomenon has previously reported and accepted on prostate cancer cases as a distinct clinico pathological entity in uro-pathology.
📊
Key Findings & Data:This review has evaluated the ‘’vanishing endometrial carcinoma’’ phenomenon through observing three similar cases and available literature reports.
💡
Conclusion & Impact:In conclusion, recognition of the concept, the vanishing endometrial carcinoma, might be a useful for gyneco logic pathologist and gynecologic oncologist in order to prevent mismanagement and medico-legal ligitation.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

“Vanishing carcinoma” phenomenon has previously reported and accepted on prostate cancer cases as a distinct clinico pathological entity in uro-pathology. However, although it may be seen in cervical and endometrial carcinoma, it has not been evaluated by extensively in gynecology literature. This review has evaluated the ‘’vanishing endometrial carcinoma’’ phenomenon through observing three similar cases and available literature reports. With this respect, causes and occur rence rates of the ‘’vanishing endometrial carcinoma’’ has been discussed. Also, clinical indications including stage and prognosis of the disease have been evaluated, and suggestions have been made on how to determine if it is a really van ishing case. In conclusion, recognition of the concept, the vanishing endometrial carcinoma, might be a useful for gyneco logic pathologist and gynecologic oncologist in order to prevent mismanagement and medico-legal ligitation.

Özet

“Vanishing karsinom” fenomeni üro-patolojide bildirilen prostat kanseri vakalarında, farklı bir klinik ve patolojik durum olarak daha önce bildirilmiş ve kabul edilmiştir. Diğer yandan, bu durum servikal ve endometrial karsinoma vakalarında görülebilme sine rağmen, jinekoloji literatüründe yoğun olarak ortaya konmamıştır. Bu makale “vanishing endometrial karsinom’’ fenomenini üç benzer vaka ve mevcut literatür bilgileri ışığında ele almıştır. Bu doğrultuda, ‘’vanishing endometrial karsinom’’ fenomeninin sebepleri ve görülme sıklığı tartışılmış, prognoz ve aşamaları içeren klinik göstergeler değerlendirilmiş ve vakanın gerçekten böyle bir fenomen olduğunun nasıl belirlenebileceği ile ilgili öneriler ortaya konmuştur. Sonuçta, vanishing endome trial karsinom konseptinin tanımlanması jinekolojik patolojist ve jinekolojik onkolojistler için olayı yanlış değerlendirme ve yönetme ve mediko-legal süreçlerden korunma anlamında faydalı olabilir.

🔖

Cite This Article

KARACA, M., AYHAN, A., DURSUN, P. (2010). Endometriyal kanserlerde “vanishing cancer phenomenon”: üç klinik vaka ve Literatür değerlendirmesi. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 20 - Sayı: 3, 175–181. https://ajindex.com/articles/323215

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000
  2. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 89: 1765-1772, 2000
  3. Stovall TG, Solomon SK, Ling FW. Endometrial samp ling prior to hysterectomy. Obstet Gynecol 74: 105, 1989
  4. Vorgias G, Lekka J, Katsoulis M, et al. Diagnostic ac curacy of prehysterectomy curettage in determining tumor type and grade in patients with endometrial cancer. MedGenMed 14: 7, 2003
  5. Epstein E, Ramirez A, Skoog L, Valentin L. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal ble eding. Acta Obstet Gynecol Scand 80: 1131-1136, 2001
  6. Tiufekchieva E, Slavchev B, Mainkhard K. The diag nostic value of dilatation and curettage in endometrial carcinoma. Akush Ginekol 37: 33-36, 1998
  7. Lampe P, Kurzl R, Hantschmann P. Reliability of tumo ur typing of endometrial carcinoma in prehysterectomy curettage. Int J Gynecol Pathol 14: 2-6, 1995
  8. Larson DM, Johnson KK, Broste SK, et al. Compari son of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 86: 38-42, 1995
  9. Dubé V, Macdonald D, Allingham-Hawkins DJ, et al. Vanishing endometrial carcinoma. Int J Gynecol Pathol 26: 271-7, 2007
  10. Mittal K, Da Costa D. Endometrial hyperplasia and car cinoma in endometrial polyps: clinicopathologic and follow-up findings. Int J Gynecol Pathol 27: 45-48, 2008
  11. Marchesoni D, Driul L, Mozzanega B, et al. Intraepithe lial G3 adenocarcinoma of the endometrium after ta moxifen treatment. Arch Gynecol Obstet 271: 62-65, 2005
  12. Stovall TG, Photopulos GJ, Poston WM, et al. Pipelle endometrial sampling in patients with known endo metrial carcinoma. Obstet Gynecol 77: 954-956, 1991
  13. Eifel PJ, Ross J, Hendrickson M, et al. Adenocarcino ma of the endometrium. Analysis of 256 cases with di sease limited to the uterine corpus: treatment compa risons. Cancer 52: 1026-1031, 1983
  14. Goldstein NS, Begin LR, Grody WW, et al. Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the ‘’vanishing cancer phenomenon’’. Am J Surg Pathol 19: 1002-1009, 1995
  15. Bostwick DG, Bostwick KC. 'Vanishing' prostate can cer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases. BJU Int 94: 57-58, 2